Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Angiotensin-converting enzyme inhibition: side effects and risks].

H Schilling1, F Scheler

  • 1Georg-August Universität Göttingen, Abteilung für Nephrologie und Rheumatologie.

Zeitschrift Fur Kardiologie
|January 1, 1988
PubMed
Summary

Adverse effects of angiotensin-converting enzyme (ACE) inhibitors are rare due to improved understanding and patient selection. Careful dosage adjustment based on renal function is crucial to prevent toxicity and manage high-risk patients effectively.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ordered nanopore arrays with large interpore distances via one-step anodization.

Nanoscale·2018
Same author

[Juvenile idiopathic epiretinal membrane].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2015
Same author

[Surgical treatment of neovascular glaucoma].

Klinische Monatsblatter fur Augenheilkunde·2014
Same author

[Endoresection of large uveal melanomas after pretreatment by single-dose stereotactic convergence irradiation with the leksell gamma knife--first experience on 46 cases].

Klinische Monatsblatter fur Augenheilkunde·2006
Same author

Ruthenium-106 plaque brachytherapy for symptomatic vasoproliferative tumours of the retina.

The British journal of ophthalmology·2006
Same author

[Morphologic classification of choroidal invasion of retinoblastoma].

Journal of Tongji Medical University = Tong ji yi ke da xue xue bao·2003

Area of Science:

  • Pharmacology and Therapeutics
  • Cardiovascular Medicine
  • Nephrology

Context:

  • Angiotensin-converting enzyme (ACE) inhibitors are widely prescribed for cardiovascular and renal conditions.
  • Understanding the specific adverse effects and risk factors is essential for safe patient management.
  • Previous concerns regarding adverse events have been mitigated by advancements in drug knowledge and patient stratification.

Purpose:

  • To delineate the spectrum of adverse effects associated with ACE inhibitors.
  • To identify patient populations at increased risk for specific adverse events.
  • To emphasize the importance of individualized dosage adjustments and risk assessment in ACE inhibitor therapy.

Summary:

  • Adverse effects of ACE inhibitors are categorized into substance-specific (e.g., neutropenia, proteinuria) and mechanism-related (e.g., hypotension, cough, angioedema).

Related Experiment Videos

  • Current low incidence is attributed to enhanced pharmacokinetic/pharmacodynamic knowledge, leading to optimized dosing and improved identification of high-risk individuals.
  • High-risk groups include patients with renal insufficiency, stimulated renin-angiotensin-aldosterone systems (renovascular hypertension, heart failure), and collagen vascular diseases (e.g., lupus, scleroderma) due to neutropenia risk. Life-threatening angioedema can occur early post-administration.

    • Impact:

    • Optimized ACE inhibitor prescribing practices, minimizing adverse events and enhancing patient safety.
    • Improved clinical decision-making for initiating and managing ACE inhibitor therapy, particularly in vulnerable populations.
    • Reduced healthcare burden associated with preventable drug-related morbidities.